Smruthi Organics Reports Decline in Performance for Q4 2023

Smruthi Organics, a microcap pharmaceutical company, recently announced its financial results for the quarter ending December 2023. The company's stock has been given a 'Sell' call by MarketsMOJO. According to the financial report, Smruthi Organics has seen a significant decline in its performance, with a score of -20 compared to 1 in the previous quarter. This is a concerning trend for the company. One of the major factors contributing to this decline is the decrease in net sales, which have fallen by 29.5% to Rs 23.48 crore compared to the average net sales of the previous four quarters, which was Rs 33.30 crore. This indicates a negative trend in the company's sales in the near term. The company's profit before tax (PBT) has also taken a hit, with a decrease of 274.3% to Rs -2.95 crore compared to the average PBT of the previous four quarters, which was Rs 1.69 crore. Similarly, the profit after tax (PAT) has also fallen by 274.8% to Rs -2.29 crore compared to the average PAT of the previous four quarters, which was Rs 1.31 crore. In addition, Smruthi Organics has also seen a decline in its operating profit (PBDIT) and operating profit margin, which are at their lowest in the last five quarters. This indicates a decrease in the company's efficiency and profitability. The company's earnings per share (EPS) have also decreased to Rs -2.00, which is the lowest in the last five quarters. This shows a decline in profitability and lower earnings for shareholders. Overall, Smruthi Organics has reported a negative financial performance for the quarter ending December 2023. Investors should take note of these results and make informed decisions regarding their investments in the company.